BioStatus was formed in 2000 by Paul Smith, Stefan Ogrodzinski and Laurence Patterson (pictured right).
Since then, the company has grown organically resulting in a small, sustainable enterprise that has invested back into R&D, creating three spin out pharmaceutical companies - OncoTherics , BioSuspensions and BioTherics.
BioStatus is recognised as a pioneer in the development of novel far-red fluorescent DNA dyes. Customer feedback recognises the BioStatus brand as synonymous with good quality products that add real value to research and diagnostics.
The company is highly regarded as a niche player in the market, offering in-depth support and excellent service in cell analysis.
In October 2012, the Royal Society of Chemistry awarded BioStatus the prestigious "2012 Teamwork in Innovation Award". The award was made in recognition of the company's "worldwide exploitation and impact of novel fluorescent molecular probes and cell detection technologies in drug discovery, clinical diagnostics and the Life Sciences".
You can find out more about us by clicking on the icons below:-
BioStatus is a Private Limited Company, registered in England and Wales
Company No: 03079239  : VAT registration No: GB 755 5893 80